- Absorica: Treatment of severe recalcitrant nodular acne in patients 12 years of age and older
- Amnesteem, Claravis, Myorisan, Sotret, Zenatane: Treatment of severe recalcitrant nodular acne
ABSORICATM, AMNESTEEMR, CLARAVISTM, MYORISANTM, SOTRETR, ZENATANETM (isotretinoin)
HNCA: Level l w/PA if dose is > 100 mg/day or if duration > 150 days
AND
AND
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
Topical Retinoids | Cream: 0.1%; Gel: 0.1%, 0.3% | N/A |
tretinoin (Retin-AR) | Cream: 0.025%, 0.05%, 0.1%; Gel: 0.01%, 0.025% Apply topically QD | N/A |
tretinoin microsphere (Retin-A MicroR) | Microsphere Gel: 0.04%, 0.1% Apply topically QD | N/A |
TazoracR (tazarotene) | Cream: 0.05%, 0.1%; Gel: 0.05%, 0.1% Apply topically QD | N/A |
Topical Antibiotics | Gel:5% benzoyl peroxide/3% erythromycin Apply topically BID |
|
clindamycin (Cleocin TR, ClindagelR, ClindamaxR) | Solution: 1%; Gel: 1%; Lotion: 1% Apply topically BID | N/A |
benzoyl peroxide-clindamycin phosphate (DuacR) | Gel: 1.2% clindamycin/5% benzoyl peroxide Apply topically QD | N/A |
erythromycin (EmgelR, ErygelR) | Solution: 2%; Gel:2% Apply topically QD to BID | N/A |
sulfacetamide 10%/sulfur 5% | Cream: 10% sulfacetamide/5% sulfur Apply topically QD to TID | N/A |
Oral Antibiotics | Varies: 125-250 mg PO Q6H for 2 wks, then decrease to 125-500 mg PO QD or QOD | 1 gm/day |
erythromycin (EESR, Erythromycin Base FilmtabR,Ery-TabR, ErycR) | 250-500 mg PO BID | 1 gm/day |
minocycline (DynacinR, MyracR, MinocinR) | IR: 100 mg PO BID ER: 1 mg/kg PO QD | 200 mg/day |
doxycycline (MonodoxR) | 50-100 PO mg PO QD | 200 mg/day |
Drug | Dosing Regimen | Authorization Limit | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Absorica, Amnesteem, Claravis, Myorisan, Sotret, Zenatane | 0.5 - 1 mg/kg/day PO divided into 2 doses
| Up to 20 weeks |